VIDEO: Pilocarpine drives improvement in near vision in phase 2 studies

ByMichael R. Robinson, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In this Healio Video Perspective from the virtual AAO annual meeting, Michael R. Robinson, MD, vice president, global therapeutic area head, ophthalmology, AbbVie, breaks down studies investigating presbyopia-treating eye drops.

Published by:

Sources/Disclosures

Collapse

Source:

Robinson MR. Two phase 2b study results for the development of a proprietary formulation for the treatment of presbyopia. Presented at: American Academy of Ophthalmology annual meeting; Nov. 13-15, 2020 (virtual meeting).

Read more about

presbyopia

eye drop

pilocarpine

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment